Published in ISRN Dermatol on April 11, 2013
A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma. BMC Cancer (2014) 0.88
TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma. Oncol Lett (2016) 0.75
Vitamins and Melanoma. Cancers (Basel) (2015) 0.75
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg (2005) 3.80
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62
Melanoma: from mutations to medicine. Genes Dev (2012) 2.59
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst (2010) 2.56
MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer (2008) 2.37
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer (2009) 2.26
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet (2011) 2.24
Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22
Epidemiology of invasive cutaneous melanoma. Ann Oncol (2009) 2.21
The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin (2010) 1.86
Clinical recognition of early invasive malignant melanoma. BMJ (1990) 1.75
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol (2011) 1.75
Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol (2008) 1.63
Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev (2009) 1.60
The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol (2010) 1.55
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol (2006) 1.50
Targeting mutant BRAF in melanoma: current status and future development of combination therapy strategies. Cancer J (2012) 1.18
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer (2009) 1.15
Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol (2007) 1.11
Surgery for distant melanoma metastasis. Cancer J (2012) 1.03
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm). Cancer (2009) 1.03
Reviews on sun exposure and artificial light and melanoma. Prog Biophys Mol Biol (2011) 1.02
Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci (2011) 1.01
Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol (2010) 0.99
Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control (2005) 0.98
Reflectance confocal microscopy for pigmentary disorders. Exp Dermatol (2009) 0.95
Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg (2012) 0.92
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol (2011) 0.89
Isolated limb infusion: a review. J Surg Oncol (2009) 0.88
Skin cancer in asians: part 2: melanoma. J Clin Aesthet Dermatol (2009) 0.87
Melanoma staging: facts and controversies. Clin Dermatol (2010) 0.86
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. Surgery (2011) 0.86
Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha. Curr Opin Oncol (2011) 0.86
Cutaneous melanoma in the elderly. Melanoma Res (2009) 0.85
Fine needle aspiration cytology of palpable and nonpalpable lymph nodes to detect metastatic melanoma. J Natl Cancer Inst (2011) 0.85
Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br J Dermatol (2007) 0.84
Outcomes for lymph node-positive cutaneous melanoma over two decades. World J Surg (2011) 0.83
Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg (2009) 0.83
Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol (2010) 0.81
Role of radiation therapy in cutaneous melanoma. Cancer J (2012) 0.79
Skin cancer in skin of color. Cutis (2012) 0.77
An update on risk factors, prognosis and management of melanoma patients. G Ital Dermatol Venereol (2012) 0.77
New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB). Expert Rev Anticancer Ther (2011) 0.77
Videodermoscopic pattern analysis of acral melanocytic nevi. J Dermatol (2011) 0.76
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med (2014) 4.71
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res (2006) 2.36
Dermoscopic changes in melanocytic naevi in children during digital follow-up. Acta Derm Venereol (2012) 1.99
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol (2003) 1.75
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol (2008) 1.65
Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev (2004) 1.55
Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. AJR Am J Roentgenol (2007) 1.55
Contrast-enhanced ultrasound for characterizing lymph nodes with focal cortical thickening in patients with cutaneous melanoma. AJR Am J Roentgenol (2011) 1.55
The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med (2006) 1.53
Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol (2002) 1.52
Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med (2006) 1.51
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol (2009) 1.36
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev (2004) 1.34
Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol (2006) 1.22
Distant muscular (gluteus maximus muscle) metastasis from laryngeal squamous cell carcinoma. Acta Otolaryngol (2005) 1.15
Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol (2010) 1.15
Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer (2012) 1.12
Immunosuppression and melanocyte proliferation. Melanoma Res (2009) 1.12
Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev (2013) 1.09
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases. J Neurooncol (2014) 1.09
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord (2007) 1.07
Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology (2009) 1.03
Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent. J Ultrasound Med (2004) 1.02
A case of malignant melanoma arising from an acquired agminated melanocytic naevus. Acta Derm Venereol (2007) 1.02
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol (2007) 1.01
Glutathione transferases as targets for cancer therapy. Anticancer Agents Med Chem (2009) 0.96
Imaging of soft-tissue tumors. J Magn Reson Imaging (2012) 0.93
Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor-alpha to patients with soft tissue limb sarcoma. Int J Cancer (2003) 0.93
Deep neck infection with dental origin: analysis of 85 consecutive cases (2000-2006). Acta Otolaryngol (2008) 0.93
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol (2004) 0.92
The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol (2003) 0.92
Histological features of periprosthetic mammary capsules: silicone vs. polyurethane. Aesthetic Plast Surg (2010) 0.91
Primary cutaneous mantle cell lymphoma. Acta Derm Venereol (2011) 0.91
Treatment of metastatic melanoma with electrochemotherapy. J Surg Oncol (2014) 0.91
Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle. Head Neck (2003) 0.91
Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am J Surg Pathol (2013) 0.90
Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions. BMC Health Serv Res (2012) 0.88
Unusual cause of small bowel perforation: metastasis of a subcutaneous angiosarcoma of the head. Int J Colorectal Dis (2005) 0.88
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa). World J Surg Oncol (2014) 0.88
Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Acta Derm Venereol (2009) 0.87
Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol (2008) 0.87
Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine (2012) 0.87
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. Surgery (2011) 0.86
MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol (2008) 0.86
Cancer vaccine development: on the way to break immune tolerance to malignant cells. Exp Cell Res (2004) 0.86
The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol (2012) 0.86
Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP). J Photochem Photobiol B (2007) 0.86
Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev (2009) 0.85
Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study. Melanoma Res (2003) 0.85
Occurrence of squamous cell carcinoma in an area of lichen simplex chronicus: case report and pathogenetic hypothesis. J Cutan Med Surg (2012) 0.85
Imiquimod for the treatment of classical Kaposi's sarcoma. Acta Derm Venereol (2010) 0.84
Targeting DSG3: from pemphigus to squamous cell carcinoma. Expert Opin Ther Targets (2013) 0.84
The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem (2010) 0.84
Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep (2011) 0.83
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma. Am J Surg (2002) 0.83
Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. J Immunol (2002) 0.83
Bullous scabies simulating pemphigoid. J Cutan Med Surg (2011) 0.83
Colorectal cancer vaccines: principles, results, and perspectives. Gastroenterology (2004) 0.83
Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. J Am Acad Dermatol (2003) 0.82
Effectiveness of different substrate materials for in vitro sunscreen tests. J Dermatol Sci (2009) 0.82
Follow-up of melanoma: a survey of Italian hospitals. Dermatology (2013) 0.82
Surgical treatment of melanoma: a survey of Italian hospitals. Dermatology (2013) 0.82
Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol (2008) 0.82
Cervical necrotizing fasciitis: an unusual complication of genuine peritonsillar abscess. J Otolaryngol (2005) 0.82
Nuclear GSK-3β segregation in desmoid-type fibromatosis. Histopathology (2013) 0.81
Melanoma in skin affected with keratoderma palmoplantaris hereditaria (Mal de Meleda): Treatment with excision and grafting. J Am Acad Dermatol (2009) 0.81
Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol (2010) 0.81
Large plaque type blue nevus with subcutaneous cellular nodules. Eur J Dermatol (2009) 0.81
The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study. J Oral Pathol Med (2013) 0.81
Composite hemangioendothelioma of the oral cavity: case report and review of the literature. Head Neck (2008) 0.81
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol (2009) 0.81
Nevus spilus and melanoma: case report and review of the literature. J Cutan Med Surg (2010) 0.81
Biochip technology for the serological diagnosis of bullous pemphigoid. ISRN Dermatol (2012) 0.81
Strategies to enhance the anticancer potential of TNF. Front Biosci (2008) 0.81
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol (2014) 0.80
Principles of gene microarray data analysis. Adv Exp Med Biol (2007) 0.80
Giant cell tumour (central giant cell lesion) of the maxilla. Acta Otolaryngol (2006) 0.80
Verrucous cutaneous sarcoidosis in an adolescent with dark skin. Eur J Dermatol (2010) 0.80
Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol Rep (2006) 0.80
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int (2005) 0.79
Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer (2002) 0.79
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol (2006) 0.79
Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma. Ann Surg Oncol (2006) 0.79
The melanoma molecular map project. Melanoma Res (2008) 0.79